175 related articles for article (PubMed ID: 23868571)
21. Correlation between NS5A dimerization and hepatitis C virus replication.
Lim PJ; Chatterji U; Cordek D; Sharma SD; Garcia-Rivera JA; Cameron CE; Lin K; Targett-Adams P; Gallay PA
J Biol Chem; 2012 Aug; 287(36):30861-73. PubMed ID: 22801423
[TBL] [Abstract][Full Text] [Related]
22. Charged residues in hepatitis C virus NS4B are critical for multiple NS4B functions in RNA replication.
Blight KJ
J Virol; 2011 Aug; 85(16):8158-71. PubMed ID: 21680530
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus NS5A inhibitor daclatasvir allosterically impairs NS4B-involved protein-protein interactions within the viral replicase and disrupts the replicase quaternary structure in a replicase assembly surrogate system.
Zhang Y; Zou J; Zhao X; Yuan Z; Yi Z
J Gen Virol; 2019 Jan; 100(1):69-83. PubMed ID: 30516462
[TBL] [Abstract][Full Text] [Related]
24. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.
Paul D; Hoppe S; Saher G; Krijnse-Locker J; Bartenschlager R
J Virol; 2013 Oct; 87(19):10612-27. PubMed ID: 23885072
[TBL] [Abstract][Full Text] [Related]
25. NS4B self-interaction through conserved C-terminal elements is required for the establishment of functional hepatitis C virus replication complexes.
Paul D; Romero-Brey I; Gouttenoire J; Stoitsova S; Krijnse-Locker J; Moradpour D; Bartenschlager R
J Virol; 2011 Jul; 85(14):6963-76. PubMed ID: 21543474
[TBL] [Abstract][Full Text] [Related]
26. ER targeting and retention of the HCV NS4B protein relies on the concerted action of multiple structural features including its transmembrane domains.
Boleti H; Smirlis D; Dalagiorgou G; Meurs EF; Christoforidis S; Mavromara P
Mol Membr Biol; 2010 Jan; 27(1):45-62. PubMed ID: 20001747
[TBL] [Abstract][Full Text] [Related]
27. NS5A Domain 1 and Polyprotein Cleavage Kinetics Are Critical for Induction of Double-Membrane Vesicles Associated with Hepatitis C Virus Replication.
Romero-Brey I; Berger C; Kallis S; Kolovou A; Paul D; Lohmann V; Bartenschlager R
mBio; 2015 Jul; 6(4):e00759. PubMed ID: 26152585
[TBL] [Abstract][Full Text] [Related]
28. Formation and function of hepatitis C virus replication complexes require residues in the carboxy-terminal domain of NS4B protein.
Aligo J; Jia S; Manna D; Konan KV
Virology; 2009 Oct; 393(1):68-83. PubMed ID: 19703698
[TBL] [Abstract][Full Text] [Related]
29. Dual topology of the processed hepatitis C virus protein NS4B is influenced by the NS5A protein.
Lundin M; Lindström H; Grönwall C; Persson MAA
J Gen Virol; 2006 Nov; 87(Pt 11):3263-3272. PubMed ID: 17030859
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory.
Gouttenoire J; Penin F; Moradpour D
Rev Med Virol; 2010 Mar; 20(2):117-29. PubMed ID: 20069613
[TBL] [Abstract][Full Text] [Related]
31. Development and characterization of a replicon-based phenotypic assay for assessing HCV NS4B from clinical isolates.
Rajyaguru S; Yang H; Martin R; Miller MD; Mo H
Antiviral Res; 2013 Nov; 100(2):328-36. PubMed ID: 24013002
[TBL] [Abstract][Full Text] [Related]
32. Surfeit 4 Contributes to the Replication of Hepatitis C Virus Using Double-Membrane Vesicles.
Kong L; Aoyagi H; Yang Z; Ouyang T; Matsuda M; Fujimoto A; Watashi K; Suzuki R; Arita M; Yamagoe S; Dohmae N; Suzuki T; Suzuki T; Muramatsu M; Wakita T; Aizaki H
J Virol; 2020 Jan; 94(2):. PubMed ID: 31645450
[TBL] [Abstract][Full Text] [Related]
33. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.
Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R
Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163
[TBL] [Abstract][Full Text] [Related]
34. Cellular OCIAD2 protein is a proviral factor for hepatitis C virus replication.
Yang Z; Ouyang T; Aoyagi H; Wang T; Xing X; Zhang Y; Wang Y; Li Y; Aizaki H; Li S; Kong L
Int J Biol Macromol; 2021 Oct; 188():147-159. PubMed ID: 34371038
[TBL] [Abstract][Full Text] [Related]
35. A genetic interaction between hepatitis C virus NS4B and NS3 is important for RNA replication.
Paredes AM; Blight KJ
J Virol; 2008 Nov; 82(21):10671-83. PubMed ID: 18715921
[TBL] [Abstract][Full Text] [Related]
36. Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy.
Lee C
Arch Pharm Res; 2011 Sep; 34(9):1403-7. PubMed ID: 21975800
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of Serine 225 in Hepatitis C Virus NS5A Regulates Protein-Protein Interactions.
Goonawardane N; Gebhardt A; Bartlett C; Pichlmair A; Harris M
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615203
[TBL] [Abstract][Full Text] [Related]
38. Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipper.
Welker MW; Susser S; Welsch C; Perner D; Füller C; Kronenberger B; Herrmann E; Zeuzem S; Sarrazin C
J Viral Hepat; 2012 Nov; 19(11):775-83. PubMed ID: 23043384
[TBL] [Abstract][Full Text] [Related]
39. Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.
Boson B; Denolly S; Turlure F; Chamot C; Dreux M; Cosset FL
Gastroenterology; 2017 Mar; 152(4):895-907.e14. PubMed ID: 27932311
[TBL] [Abstract][Full Text] [Related]
40. Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A.
Sun JH; O'Boyle DR; Fridell RA; Langley DR; Wang C; Roberts SB; Nower P; Johnson BM; Moulin F; Nophsker MJ; Wang YK; Liu M; Rigat K; Tu Y; Hewawasam P; Kadow J; Meanwell NA; Cockett M; Lemm JA; Kramer M; Belema M; Gao M
Nature; 2015 Nov; 527(7577):245-8. PubMed ID: 26536115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
